Wave Life Sciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul Bolno, with a market cap of $1.4B.
Common questions about Wave Life Sciences
Wave Life Sciences is scheduled to report earnings for Q1 2026 on April 28, 2026 before market open. Analysts estimate revenue of $8.5M.
Wave Life Sciences has approximately 268 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.